Search results
How AI Is Revolutionizing Drug Development
New York Times· 37 minutes agoIn high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. Steve Lohr reported from the Terray...
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 7 hours agoNovo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its...
Millions of Americans in insulin deserts worry that recent price reductions could one day disappear
WVLT-TV Knoxville· 55 minutes agoCharlene Davis sleeps on her living room floor in Atlanta to help ease her back pain and make it...
Millions of Americans in insulin deserts worry that recent price reductions could one day disappear
KCTV 5 Kansas City· 55 minutes agoCharlene Davis sleeps on her living room floor in Atlanta to help ease her back pain and make it...
Grifols prepares for late-stage plans with plasma-derived medicines in 2024
Pharmaceutical Technology via Yahoo Finance· 4 hours agoIn an exclusive interview with Pharmaceutical Technology, Schüttrumpf outlined the plasma...
Millions of Americans in insulin deserts worry that recent price reductions could one day disappear
Black Hills FOX· 55 minutes agoCharlene Davis sleeps on her living room floor in Atlanta to help ease her back pain and make it...
New drug's potentially fatal side effects obscured by 'soothing acronym,' doctors say
LA Times via AOL· 8 hours agoGenevieve Lane, who took Leqembi, died of a mysterious side effect called ARIA. Her death, and those...
Analyst Report: Cencora Inc
Argus Research via Yahoo Finance· 6 hours agoHeadquartered in Conshohocken, Pennsylvania, Cencora, formerly AmerisourceBergen, is one of the nation's largest pharmaceutical distributors. The company
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Motley Fool via Yahoo Finance· 1 day agoIf you're eyeing an investment in Madrigal Pharmaceuticals (NASDAQ: MDGL), now's the time to imagine...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 4 days agoBUSINESS In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly was on...
